Anti-SARS-CoV-2 Spike S1 (RBD) Neutralizing Antibody (V3S-0623-XY134) (CAT#: V3S-0623-XY134)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody 47D1 is a human mAb specific for SARS-CoV-2 Spike S1 protein. The antibody binds only to one side of the receptor binding surface on the RBD. Neutralization by the antibody is achieved independent of interfering RBD-ACE2 binding. A crystal structure of the mAb-RBD complex shows that the IF motif at the tip of the antibody CDR H2 interacts with a hydrophobic pocket in the RBD. It neutralizes SARS-CoV-2 by suppressing spike-mediated membrane fusion, rather than blocking virus binding to ACE2-expressing cells.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Epitope Receptor-binding domain (RBD)
Function Suppresses spike-mediated membrane fusion, but not blocking the virus binding to ACE2-expressing cells.
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry